Paul Bolno

Paul Bolno is the current President & CEO at WAVE Life Sciences. Prior to this, they were with GlaxoSmithKline for 4 years as the VP Worldwide Business Development - Asia. Paul was also responsible for representing SR One, GSK’s corporate venture fund, in Asia.

From 2004 to 2009, Bolno was the Director of Research at Two River LLC.

Bolno has extensive experience in business development and external innovation. Paul has a proven track record in leading and executing deals in the Asia-Pacific region. Paul is also an active member of various leadership teams and boards, overseeing investments and operations for R&D organizations.

Paul Bolno's educational career includes a MD from MCP-Hahnemann University School of Medicine, an MBA from Drexel University's LeBow College of Business, and a BA from Emory University.

Some direct reports include Kyle Moran - Chief Financial Officer, Chris Francis - SVP, Corporate Development, Head of Emerging Areas, and Keith Regnante - Chief Financial Officer.